Proteins Express Health
More than just a vial...
New technologies allow scientists to measure thousands of proteins
from a vial of blood.
...powerful health insights
We leverage health prediction algorithms across healthcare ecosystem
Eddie Adams, PhD
Chief Product & Scientific Officer
Leads scientific innovation and product development at Health Outlook. Extensive experience in liquid biopsy diagnostics, epigenetics, and molecular diagnostics. Previously led R&D efforts at Micronoma, Active Motif, and MO BIO Laboratories (acquired by Qiagen). Former Director of Molecular Diagnostics at NanoMR. Inventor on numerous patents in diagnostics, epigenetics, sample preparation, and nanotechnology. Holds a BS in Biotechnology from Rochester Institute of Technology and a PhD in Biological Chemistry from MIT.
Nicola Jessen
Head of Marketing
Drives Health Outlook’s go-to-market, leveraging deep expertise in digital transformation, customer collaboration, and growth initiatives. Previously led digitalization and automation efforts at Siemens Healthineers across Central Eastern Europe and Central Asia. Held multiple global roles in strategy, M&A, digital transformation, and product development. Extensive experience as Head of Marketing at startups, focusing on market expansion and innovation. MS in Informatics and Information Systems from the University of Augsburg.
John Marques
Director of Origination, Velocity Life
Brings a diverse background across entertainment, jewelry, and life sciences. Currently leads origination at Velocity Life Settlements, with prior experience as Vice President at FairMarket Life Settlements and multiple Fund Manager roles. Expertise in life settlements with a bachelor’s degree from DePaul University.
Adam Brzozowski
Head of Data Insights & Analytics
Leads advanced data science applications for disease modeling. Previously Vice President of Data Insights & Analytics at Modivcare. Holds an ALM in Data Science from Harvard University, an MBA from Quinnipiac University, and triple BA degrees in Mathematical Economics, History, and Political Science from Eastern Connecticut State University.
Sharon Reese
Head of Accounting
Oversees Health Outlook’s accounting and financial operations, ensuring compliance, reporting accuracy, and strategic financial management. CFO Partner at TechCXO with a strong track record in life sciences. Previously served as Chief Financial Officer and Vice President of Finance & Compliance at AgNovos Bioscience, BioReliance, and United BioSource Corporation. Holds a BS in Accounting from Penn State University and is a Certified Public Accountant.
Joe El-Khoury, PhD, DABCC
Assoc. Professor & Lab Director
Leads clinical research and laboratory operations focused on advancing biomarker discovery and diagnostics. He is also the Director of the Clinical Chemistry Laboratory at Yale New Haven Health and an Associate Professor of Laboratory Medicine at Yale School of Medicine. Board-certified by the American Board of Clinical Chemistry and a fellow of the ADLM Academy. Extensive experience in clinical diagnostics, kidney disease biomarkers, and mass spectrometry applications.
John Turcotte
Lab Manager
As Chemistry Technical Supervisor and Quality Assurance Officer, leads day-to-day laboratory operations. Previously Laboratory Supervisor – Chemistry at Griffin Hospital and Laboratory Supervisor at Cornell Scott – Hill Health Center, overseeing diagnostic testing, assay validation, equipment maintenance, and compliance with accreditation standards. Brings extensive experience in clinical laboratory management, process optimization, and personnel training.
Eric Faulkner
Chief Information Officer
Oversees IT strategy and digital transformation. Extensive experience in scaling software, M&A integration, and product development. Held senior leadership roles at Corcentric, Determine, 10Pearls, and Federated Sports & Gaming. MS in Information Technology from Virginia Tech.
Tim Opler, PhD
Chairman & Co-Founder,
Health Outlook
Managing Director at Stifel’s Global Healthcare Group. Co-founded Torreya, later acquired by Stifel. Nearly 20 years of experience in life sciences advisory, completing over 150 strategic and financing transactions. Former Vice President of Strategy at FibroGen and healthcare investment banker at Credit Suisse First Boston. PhD in Economics from UCLA.
Tadd Wessel
Founder & Managing Partner, Petrichor
Founder and Managing Partner of Petrichor, a healthcare-focused investment firm, and Scion Life Sciences, a Petrichor affiliate. Over 25 years of experience in life sciences investing, previously Partner at OrbiMed Advisors. Serves on multiple boards, including ITM and Aurion Biotech. Holds an AB in Biology from Princeton University.
Hayden Fownes
Vice President,
Petrichor
Joined Petrichor at launch, focuses on investment sourcing, execution, and portfolio management. Prior to Petrichor, Hayden worked in the Global Healthcare Investment Banking group at Bank of America, where he executed financings and M&A for clients across all life sciences subsectors. BS in Finance from Wake Forest University.
Adam Morgan
Partner, Avego &
CIO, Velan Capital
Nearly two decades of experience in healthcare investing and asset management. Former Senior Analyst at Broadfin Capital and Iguana Healthcare. Background in medical devices with leadership roles across engineering, sales, and strategy. BS in Chemistry and MBA from the University of Minnesota.
Andy Dannenberg, MD
Former Professor Medicine,
Weill Cornell Medical College
Partner at Emerald Bioventures. Formerly was Professor of Medicine at Weill Cornell Medical College. Author of 200+ scientific publications. Expert on inflammation and cancer. MD Wash U., St. Louis.
Paul Ridker, MD
Professor of Medicine,
Harvard University
Dr. Ridker is a cardiovascular epidemiologist and biomedical researcher whose research has provided proof-of-principle for the inflammation hypothesis of atherosclerosis and the first proven anti-inflammatory treatment for coronary artery disease.
Richard Ulevitch, PhD
Dept. Immunology,
Scripps Research Institute
Richard Ulevitch is professor of immunology and Chairman Emeritus of the Department of Immunology at The Scripps Research Institute. His career is marked by a number of seminal scientific discoveries in the field of innate immunity. He has a strong ongoing interest in implications of proteomics for science and medicine. He received a PhD in Immunology from the University of Pennsylvania.
David Shulkin, MD
Former Secretary,
Veterans Administration
Dr. Shulkin is an American physician and former U.S. Secretary of Veterans Affairs. Shulkin was also CEO of Beth Israel Medical Center and was president of Morristown Medical Center. He was the first CMO of the University of Pennsylvania Hospital.
Mark Simon
Co-Founder and Advisor, Torreya
Mark Simon is a partner at Torreya Partners, which he co-founded in 2007. He brings over 20 years of experience in advising biotech companies. He is active on numerous boards including that for the Alliance for Aging Research. Before Torreya, Simon was in investment banking at Citigroup and Robertson Stephens. Mark received an MBA from Harvard Business School.
Ravi J. Patel, DO
Board Certified Emergency Medicine
Ravi Patel is a Board Certified Emergency Physician. He completed his medical school at the West Virginia School of Osteopathic Medicine and completed his residency at the University of Missouri-Kansas City where he served as chief resident. Dr. Patel has become passionate about digital health and using health informatics to solve complex logistical and analytical problems.
Dan Lewis
Board Member, Lobesity
Accomplished C-suite executive across multiple industries. Recently, worked in healthcare as the COO of a $1.5B hospital system and in biotech as the CEO of Lobesity, a start-up company dedicated to the treatment of obesity. Successfully led the exit in 2021 and remains a Board Member. Currently, advises other start-ups in the health tech sector. Received a BA degree from Kent State University and an MA from the University of Akron.